Ruth J. Napier, Ph.D.
Affiliations: | 2013 | Biological and Biomedical Sciences | Emory University, Atlanta, GA |
Area:
Microbiology Biology, Immunology, Cell BiologyGoogle:
"Ruth Napier"Parents
Sign in to add mentor| Thomas M. Shinnick | grad student | 2013 | Emory | |
| (Development of the tyrosine kinase inhibitor imatinib mesylate as a therapeutic for tuberculosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Napier RJ, Adams EJ, Gold MC, et al. (2015) The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity. Frontiers in Immunology. 6: 344 |
| Napier RJ, Norris BA, Swimm A, et al. (2015) Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. Plos Pathogens. 11: e1004770 |
| Gold MC, Napier RJ, Lewinsohn DM. (2015) MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunological Reviews. 264: 154-66 |
| Baldwin PR, Reeves AZ, Powell KR, et al. (2015) Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 92: 693-9 |
| Napier RJ, Shinnick TM, Kalman D. (2012) Back to the future: host-targeted chemotherapeutics for drug-resistant TB. Future Microbiology. 7: 431-5 |
| Napier RJ, Rafi W, Cheruvu M, et al. (2011) Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host & Microbe. 10: 475-85 |